NCT01855529

ROPI Study : Ropivacaine Interest in Postsurgical Pain After Mastectomy

ROPI Study: Evaluation of the Interest of Ropivacaine Streaming in Postoperative Pain After Mastectomy.

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 150 (actual)
• Sponsor: Centre Jean Perrin · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

After surgery for breast cancer, the prevalence of chronic pain is estimated between 20 and 68%. They begin after surgery and may persist until more than 6 months. They respond poorly to opioid analgesics impair the quality of life. Among the different postoperative analgesic techniques used, the use of a local anesthetic infiltration continues catheter has advantages including improving the quality of analgesia, with a significant decrease in average of VAS (scale visual Analogue), a decrease in morphine consumption, improving the quality of life of patients. Our study aims to evaluate the effectiveness of a continuous local anesthetic infiltration in the control of postoperative pain after mastectomy.

Conditions

• Pain After Mastectomy

Interventions

Type	Name	Description
DRUG	Ropivacaine in one arm and placebo (NaCl) in the other arm

Timeline

• Start date: 2013-04-01
• Primary completion: 2016-08-01
• Completion: 2016-08-01
• First posted: 2013-05-16
• Last updated: 2017-09-12

Locations

1 site across 1 country: France